MarketMuse update courtesy of extract from Todd Shriber’s latest piece at ETFTrends. Shares of Pharmacyclics (NasdaqGS: PCYC), a maker of cancer treatments, surged nearly 17% Wednesday, extending a run that has seen the stock surge 80.1% this year, on news that the California-based company is mulling a sale. Citing unidentified sources, Bloombergreports that Dow component Johnson […]
Read More